BCPC Balchem Corporation

165.54USD-1.89%Mkt Cap: 5.26B USDP/E: 31.23

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and indu…

Institutional holders20 on file

Key Statistics

Company
Market Cap5.26B USD
Enterprise Value5.44B USD
Revenue (TTM)1.11B USD
Gross Profit370.63M USD
Net Income (TTM)154.84M USD
Revenue/Share34.78 USD
Last Price165.54 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.4K
CountryUS
SectorBasic Materials
IndustrySpecialty Chemicals
ISIN—
Valuation
P/E (Trailing)31.23
P/E (Forward)26.01
PEG2.88
EV/EBITDA19.56
EV/Revenue4.90
P/S4.74
P/B3.97
EPS (TTM)5.30 USD
EPS (Forward)6.36 USD
52W Range
147.1847% of range186.15
52W High186.15 USD
52W Low147.18 USD
Profitability
Gross Margin35.74%
Oper. Margin20.70%
EBITDA Margin25.07%
Profit Margin14.93%
ROE12.31%
ROA9.18%
ROIC11.94%
ROCE13.86%
Growth
Revenue Growth8.60%
Earnings Growth17.70%
Cash Flow & Leverage
Operating CF216.56M USD
CapEx (TTM)43.49M USD
FCF Margin12.58%
FCF Yield2.65%
Net Debt76.18M USD
Net Debt/EBITDA0.27
Net Debt/FCF0.55
Balance Sheet
Debt/Equity0.14
Current Ratio2.47
Quick Ratio1.29
Book Value/Sh41.69 USD
Cash/Share2.08 USD
Dividends
Fwd Div Rate0.96 USD
Trail. Div Rate0.96 USD
Div. Yield0.57%
5Y Avg Yield0.52%
Payout Ratio18.11%
Ex-Div DateDec 23, 2025
Pay DateJan 20, 2026
Splits
Last Split3:2
Split DateJan 21, 2010
Analyst Consensus
Rating—
Target (Mean)213.50 USD
Upside (mean)+29.0%
Target Range175.00 USD – 254.00 USD
175.00+29.0% to mean254.00
# Analysts4
Ownership
Shares Out.31.78M
Float31.59M
Insiders0.59%
Institutions94.14%
Short Interest
Short Ratio1.7d
Short % Float2.18%
Short % Out.1.58%
Shares Short503.64K
Short (prev mo.)493.01K
Technical
SMA 50169.85 (-2.5%)
SMA 200169.67 (-2.4%)
Beta0.85
S&P 52W Chg12.08%
Avg Vol (30d)263.22K
Avg Vol (10d)290.82K
Technical Indicators
RSI (14)38.8
MACD-0.4047
MACD Signal0.6684
MACD Hist.-1.0732
BB Upper181.18 USD
BB Middle172.68 USD
BB Lower164.17 USD
BB Width9.85%
ATR (14)3.824 USD
Vol Ratio (20d)0.74x

About Balchem (NASDAQ: BCPC)

›

Balchem (NASDAQ: BCPC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,430 employees.

The shares were at 165.54 USD on 19 November 2026, up 9.6% over 52 weeks. Its 52-week range is 147.18 USD to 186.15 USD: the price is 11.1% below the high and 12.5% above the low.

At a market capitalisation of 5.26B USD, it trades at 31.2 times trailing earnings and 26.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, so BCPC is valued in line with them. It pays a dividend yielding 0.57% (it pays out 18% of its earnings), against a median of 1.76% among the dividend payers in that peer group.

Balchem reports return on equity of 12.3%, an operating margin of 20.7% and revenue up 8.6% year over year.

Its debt exceeds its cash by 76.18M USD, a debt-to-equity ratio of 0.14. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 213.50 USD is 29.0% above the current price. The next earnings report is expected on 19 February 2027.